The European Union's drugs regulator on Thursday said it recommends approval of Eisai and Biogen's Leqembi in patients with ...

In Japan, clinical use is climbing faster, with about 4,500 people now on the drug. ARIA rates in Japan are half those in the U.S., which was also the case in the Phase 3 Clarity trial. Meanwhile, use ...

Susan Haake was a gifted pianist and organist. She enjoyed golf, loved to entertain guests, and was always ready to offer a smile, a laugh, and a listening ear. Her joyful spirit and deep compassion ...

ALBANY, N.Y. ( NEWS10) — Free memory screenings are available on Thursday afternoon at Mariott Albany on Wolf Road in honor ...

For these two Iona Prep student-athletes, who just happen to be brothers, making a difference is the name of the game.

We fully endorse the Editorial1 on the negative opinion of the European Medicines Agency of the use of lecanemab for the treatment of early Alzheimer's disease. Investigators from the European ...

Research from the College of Medicine provides promising insights into delaying the progression of Alzheimer’s disease for ...

Researchers at Texas A&M University have developed a nasal spray shown to delay disease progression in animals -- fueling hope it could one day work in humans.

Residents from Erie and surrounding counties participated in this year’s Erie Shores Walk to End Alzheimer’s, raising a record-breaking $103,000 to support the care, support and research programs ...

An international collaboration led by RIKEN researchers has discovered how unusual spherical structures form in the brains of ...

As we count down toward the December readout of Cassava Sciences’ simufilam Phase 3 clinical trial in Alzheimer’s disease, it ...